Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
Radioimmunoconjugates
RECIST
recommended phase 2 dose (RP2D) Drug Approval and Regulatory Issues Answer 16.1 Question 18.1
reduced folate carrier (RFC)
regulator of cullin 1 (Roc1)
response evaluation criteria in solid tumors (RECIST)
retinoblastoma (RB) Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer DNA Repair, Apoptotic Pathways, CDK Inhibitors
ribonucleotide reductase (RNR) inhibition purine analogs polymorphism in thiopurine methyltransferase (TPMT)
rituximab, ifosfamide, carboplatin, etoposide (R-ICE) Alkylating Agents Question 2.2
RNR
RP2D
RB
refractory multiple myeloma (RRMM)
regulatory T cells (Tregs)
RFC
R-ICE
Roc1
RRMM